ARCHIVES

Phase III Regorafenib Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: McIntyre New AACI President, Salmon President Elect; Hubbard NCI AD; Underleider CIB Chief

September 30, 1988

To Become Effective Lobbyists, Scientists Seek Alliances With Patient Advocates

March 31, 1995

New ACS Program Honors Mary Lasker

August 31, 1984

Obese Men With Benign Biopsy At High Risk for Prostate Cancer

April 26, 2013

14 Institutions Awarded $100 Million for AIDS Treatment Evaluation Units

July 4, 1986

Screening Mammograms In Young Women Have Low Accuracy, Detect Few Cancers

May 28, 2010